Coronavirus Update: How Vaccines Stack Up Against Variants So Far

Boehringer Ingelheim Drops ARDS Drug

 
• By Scrip Team
  
Novavax Trial US
Novavax's vaccine showed greater than 55% efficacy against the South African B.1.351 variant • Source: Shutterstock

More from R&D

More from Scrip